Get started
Author

Ya‐Nan Jin

Observed names: Ya-Nan Jin, Yanan Jin
Observed institutions: Sun Yat-sen University, Wuhan University, Northwest University, Xi'an Medical University, Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China
ORCID: 0000-0003-0081-0030
Observed ORCID: 0000-0003-0081-0030
OpenAlex ID: A5010358752
The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis
2018 · Ji-Jin Yao, Ya-Nan Jin, et al. · BMC Cancer · 50
PDF
Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?
2017 · Ya-Nan Jin, Ji-Jin Yao, et al. · Journal of Cancer · 45
PDF
Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer
2020 · Wen-Zhuo He, Chang Jiang, et al. · Oral Oncology · 37
Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein–Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma
2017 · Ji-Jin Yao, Guan-Qun Zhou, et al. · 癌症：英文版 · 37
PDF
ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA
2024 · Yanan Jin, Jijin Yao, et al. · Cell Death and Disease · 31
Prognostic value of serum Epstein–Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein–Barr virus DNA
2017 · Ji‐Jin Yao, Li Lin, et al. · Cancer Science · 31
PDF
The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era
2018 · Ya-Nan Jin, Wang-Jian Zhang, et al. · Cancer Research and Treatment · 26
PDF
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis
2024 · Ya-Nan Jin, Meng-Yun Qiang, et al. · Cancer Immunology Immunotherapy · 21
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis
2021 · Yafei You, Chang Jiang, et al. · Cancer Immunology Immunotherapy · 17
The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study
2022 · Ya-Nan Jin, Tian-Liang Xia, et al. · BMC Cancer · 14
PDF
Regorafenib with or without a programmed cell death protein 1 antibody as third‐line treatment for microsatellite stable metastatic colorectal cancer
2022 · Wen‐Zhuo He, Lei Wang, et al. · Cancer Medicine · 13
PDF
The prognostic value of adding systemic inflammation response index to Epstein–Barr virus DNA in childhood nasopharyngeal carcinoma: A real‐world study
2022 · Ya‐Nan Jin, Bao‐Qiu Liu, et al. · Head & Neck · 13
Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?
2019 · Ji-Jin Yao, Ya-Nan Jin, et al. · Therapeutic Advances in Medical Oncology · 11
Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study
2021 · Ya-Nan Jin, Ji-Jin Yao, et al. · Radiotherapy and Oncology · 10
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression
2024 · Kunwei Peng, Yongxiang Liu, et al. · Cellular Oncology · 9
The effect of adding concurrent chemotherapy to radiotherapy for stage II nasopharyngeal carcinoma with undetectable pretreatment Epstein-Barr virus DNA: Retrospective analysis with a large institutional-based cohort
2020 · Ya-Nan Jin, Qing-Nan Tang, et al. · Translational Oncology · 9
PDF
The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy
2022 · Ji-Jin Yao, Ya-Nan Jin, et al. · Radiotherapy and Oncology · 8
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study
2021 · Ya-Nan Jin, Meng-Yun Qiang, et al. · Cancer Cell International · 7
PDF
Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma
2021 · Kunwei Peng, Huijiao Cao, et al. · Frontiers in Oncology · 7
PDF
The Effect of Adding Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Undetectable Pretreatment Epstein-Barr Virus DNA
2017 · Ya-Nan Jin, Ji-Jin Yao, et al. · Translational Oncology · 7
PDF
Predictors of Mastoiditis after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: A Dose-Volume Analysis
2016 · Ji-Jin Yao, Guan-Qun Zhou, et al. · Journal of Cancer · 7
PDF
Potential causal links of long‐term exposure to PM2.5 and its chemical components with the risk of nasopharyngeal carcinoma recurrence: A 10‐year cohort study in South China
2024 · Xurui Sun, Xiao Lin, et al. · International Journal of Cancer · 6
PDF
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer
2024 · Lin Yang, Jiahong Yi, et al. · British Journal of Cancer · 6
PDF
Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III‐IVa nasopharyngeal carcinoma: A real‐world study based on medical comorbidities
2024 · Ya‐Nan Jin, Zhi‐Wen Xiao, et al. · Head & Neck · 6
PDF
Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard Therapies
2020 · Lei Wang, Huijiao Cao, et al. · Frontiers in Oncology · 6
PDF
Works count: 38
Citation count: 448
H-index: 12
I10-index: 14
Year
Topic
Type